LEPU BIO-B Posts March 2026 Monthly Return: 1.80 Bln Shares Outstanding, No Capital Changes

Bulletin Express04-02

Lepu Biopharma Co., Ltd. filed its monthly return for the period ended 31 March 2026, confirming a stable capital structure and full compliance with Hong Kong Stock Exchange public float requirements.

The company’s authorised and issued ordinary H shares both remained at 1.80 billion, each with a par value of RMB 1.00. No new shares were issued, cancelled, or repurchased during the month, leaving treasury share holdings at zero.

Lepu Biopharma also reported that: • Total authorised/registered share capital stood unchanged at RMB 1.80 billion. • Issued share count was steady at 1.80 billion, with no movements recorded across options, warrants, convertibles, or other equity-linked instruments. • The minimum 25% public float threshold stipulated by Main Board Rule 13.32B has been met as of 31 March 2026.

The filing, submitted on 2 April 2026 by Joint Company Secretary Ms. Li Yunyi, affirms that all listing rule obligations and statutory requirements were satisfied during the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1174315525?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174315525","market":"hk","top_or_hot":-1,"title":"LEPU BIO-B Posts March 2026 Monthly Return: 1.80 Bln Shares Outstanding, No Capital Changes","media":"Bulletin Express","content":"<p>Lepu Biopharma Co., Ltd. filed its monthly return for the period ended 31 March 2026, confirming a stable capital structure and full compliance with Hong Kong Stock Exchange public float requirements.</p>\n<p>The company’s authorised and issued ordinary H shares both remained at 1.80 billion, each with a par value of RMB 1.00. No new shares were issued, cancelled, or repurchased during the month, leaving treasury share holdings at zero.</p>\n<p>Lepu Biopharma also reported that:\n• Total authorised/registered share capital stood unchanged at RMB 1.80 billion.  \n• Issued share count was steady at 1.80 billion, with no movements recorded across options, warrants, convertibles, or other equity-linked instruments.  \n• The minimum 25% public float threshold stipulated by Main Board Rule 13.32B has been met as of 31 March 2026.</p>\n<p>The filing, submitted on 2 April 2026 by Joint Company Secretary Ms. Li Yunyi, affirms that all listing rule obligations and statutory requirements were satisfied during the reporting period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU BIO-B Posts March 2026 Monthly Return: 1.80 Bln Shares Outstanding, No Capital Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU BIO-B Posts March 2026 Monthly Return: 1.80 Bln Shares Outstanding, No Capital Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lepu Biopharma Co., Ltd. filed its monthly return for the period ended 31 March 2026, confirming a stable capital structure and full compliance with Hong Kong Stock Exchange public float requirements.</p>\n<p>The company’s authorised and issued ordinary H shares both remained at 1.80 billion, each with a par value of RMB 1.00. No new shares were issued, cancelled, or repurchased during the month, leaving treasury share holdings at zero.</p>\n<p>Lepu Biopharma also reported that:\n• Total authorised/registered share capital stood unchanged at RMB 1.80 billion.  \n• Issued share count was steady at 1.80 billion, with no movements recorded across options, warrants, convertibles, or other equity-linked instruments.  \n• The minimum 25% public float threshold stipulated by Main Board Rule 13.32B has been met as of 31 March 2026.</p>\n<p>The filing, submitted on 2 April 2026 by Joint Company Secretary Ms. Li Yunyi, affirms that all listing rule obligations and statutory requirements were satisfied during the reporting period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物-B","start_time":0,"source_url":"","article_id":"1174315525","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174315525","pubTimestamp":1775121908,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Lepu Biopharma Co., Ltd. filed its monthly return for the period ended 31 March 2026, confirming a stable capital structure and full compliance with Hong Kong Stock Exchange public float...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物-B"},"translate_title":"乐普生物-B公布2026年3月月度回报：流通股18亿股，资本无变化","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"Lepu Biopharma Co., Ltd. filed its monthly return for the period ended 31 March 2026, confirming a stable capital structure and full compliance with Hong Kong Stock Exchange public float requirements.\nThe company’s authorised and issued ordinary H shares both remained at 1.80 billion, each with a par value of RMB 1.00. No new shares were issued, cancelled, or repurchased during the month, leaving treasury share holdings at zero.\nLepu Biopharma also reported that:\n• Total authorised/registered share capital stood unchanged at RMB 1.80 billion.  \n• Issued share count was steady at 1.80 billion, with no movements recorded across options, warrants, convertibles, or other equity-linked instruments.  \n• The minimum 25% public float threshold stipulated by Main Board Rule 13.32B has been met as of 31 March 2026.\nThe filing, submitted on 2 April 2026 by Joint Company Secretary Ms. Li Yunyi, affirms that all listing rule obligations and statutory requirements were satisfied during the reporting period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1174315525","isCrawlerRequest":true}